ABOUT US
ABOUT US

Star Sports Medicine Co., Ltd.

We are a China-based medical device company specializing in clinical sports medicine solutions. We offer holistic solutions for the treatment of injuries to soft tissues of rotator cuffs, ligaments and meniscus at shoulders, knees, hips, feet/ankles, elbows,and hands/wrist, as well as for the rehabilitation and  prevention of sports-related injuries,leveraging our self-developed medical implants, active equipment, associated medical consumables and surgical instruments.

We have developed four scalable core technology platforms, namely, biomaterial platform,imaging and dynamic platform, intelligent medicine platform and tissue engineering platform.

These platforms underpin the development of product matrix spanning the entire sports medicine cycle of prevention, treatment and rehabilitation.

 

As of December 31, 2025,our product portfolio encompassed 63 products spanning medical implants, surgical equipment and associated medical consumables, as well as surgical instruments and regenerative repair products. We had 27 products with Class III medical device certificates and 25 with Class II medical device certificates, the most among 

China’s sports medical device companies.11 of our products were the first of their kind to receive medical device certificates in China, and ten of them were the first of their kind to be domestically produced.we secured in aggregate over 200 regulatory approvals and registration certificates for medical devices in Europe, Southeast Asia, the Middle East and Latin America.11 of its products were the first

of their kind to receive medical device certificates in China, and 10 products were the first domestically produced products of their kind to obtain medical device certificates in China.

Thanks to its extensive sales network, we has established a strong brand presence in the field of sports medicine.

The number of hospitals that had adopted our products increased from over 1,000 as of December 31, 2023 to over 3,000 as of December 31, 2025, among which over 1,000 were Class III hospitals.